Efficacy of once-daily medium- or high-dose mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus twice-daily high-dose fluticasone/salmeterol (FLU/SAL) to control nocturnal symptoms in patients (pts) with inadequately controlled asthma

Conclusion: Both doses of MF/IND/GLY taken once daily (a.m.) improved lung function and controlled symptoms throughout the day and during the night, more effectively than twice daily high-dose FLU/SAL.

Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Chapman, K. R., Van-Zyl Smit, R., Mezzi, K., Brittain, D., Kerstjens, H. A. Tags: 05.01 - Airway pharmacology and treatment Source Type: research